NCT02058901View on ClinicalTrials.gov

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Solid Tumors
Interventions
DRUG

Sunitinib

Trial Locations (1)

1081HV

VU University Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT02058901 - Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors. | Biotech Hunter | Biotech Hunter